United Kingdom Research-Use-Only & MHRA Compliance Policy
Clear statutory separation between non-clinical in-vitro laboratory research reagents supplied by Peptide Verge (United Kingdom) and licensed medicinal products.
1. UK Human Medicines Regulations 2012 (SI 2012/1916)
All compounds listed by Peptide Verge (United Kingdom) are supplied exclusively as laboratory analytical reference materials for controlled in-vitro biochemical and cellular assays. None are licensed by the UK MHRA as medicinal products, food supplements, or cosmetics.
2. Qualified UK Purchaser Qualification
Purchases on Peptide Verge (United Kingdom) are restricted to adults aged 18+ acting on behalf of academic departments, contract research organizations (CROs), analytical testing facilities, or qualified private laboratories within the United Kingdom.
3. Strict Prohibition of Clinical or Human Use
In-vivo administration, human consumption, diagnostic use, veterinary dosing, or compounding for personal use is strictly prohibited. Peptide Verge reserves the right to cancel and refund any UK order suspected of non-laboratory misuse.
4. Controlled & Prescription-Only Screening
Compounds classified in the United Kingdom as Prescription-Only Medicines (POM) or controlled hormones are withheld from public self-checkout pending institutional compliance review.